glp 1
9 articles about glp 1 in AI news
Hims & Hers to Launch AI Weight-Loss Agent as GLP-1 Demand Surges
Hims & Hers to launch AI weight-loss agent for GLP-1 users, announced during Q1 2026 earnings call. Revenue grew 25% to $420M.
How Major Retailers Use AI to Reimagine the Customer Journey
BizTech Magazine reports that retailers like Kering and Nike use Google Cloud AI to personalize customer journeys, lifting revenue 10-30%. This matters as AI transforms omnichannel retail with real-time data and generative models.
NVIDIA Vera Rubin: One Rack Matches TOP500, 35 EU Labs Deploy
NVIDIA's Vera Rubin NVL72 delivers TOP500-class performance in a single rack, with 35 European labs deploying the system for AI and HPC.
AMD's Lemonade v10.8 Adds MCP Support, Letting Claude Desktop and Cursor Route Tasks to Local AMD GPUs
AMD-backed Lemonade v10.8, released June 17, now exposes a Model Context Protocol server, letting Claude Desktop, Cursor, and GitHub Copilot route inference tasks to local AMD Ryzen AI NPUs, Radeon GPUs, or plain CPUs — no cloud API required. The update also adds Moonshine speech-to-text, expanded R
NEMA, ASHRAE, PNNL Launch AI Data Center Framework as Power Demand Hits 175 TWh
NEMA, ASHRAE, and PNNL launched an AI data center framework addressing 70-100 kW per rack power demands as global AI electricity consumption could hit 175 TWh annually.
NVIDIA NVFP4 on Blackwell Cuts JAX Training by 1.8x in MaxText
NVIDIA NVFP4 on Blackwell achieves 1.8x training speedup over FP8 in JAX/MaxText with no claimed accuracy loss for models up to 70B, but larger-scale validation is needed.
Medvi Hits $401M in First Year, Projects $1.8B in 2026 as AI-Powered Solo Founder Telehealth Venture
Solo founder Matthew Gallagher launched telehealth company Medvi from his LA home using AI for copy, videos, and analytics. It generated $300K in month one, $1M in month two, and $401M in its first full year, now projecting $1.8B in 2026 with his brother as the only employee.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
Walmart's Sparky Chatbot Replaces OpenAI's Instant Checkout After 3x Lower Conversion Rates
Walmart is embedding its own Sparky chatbot into ChatGPT and Google Gemini after OpenAI's Instant Checkout feature saw conversion rates three times lower than traditional web purchases. The pivot highlights the challenges of 'agentic commerce' where AI agents complete purchases autonomously.